Ranibizumab for High-Risk Proliferative Diabetic Retinopathy: An Exploratory Randomized Controlled Trial

Publisher： Karger

E-ISSN： 1423-0267|235|1|34-41

ISSN： 0030-3755

Source： Ophthalmologica, Vol.235, Iss.1, 2016-0, pp. : 34-41

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Structural and Functional Assessment of Macula in Patients with High-Risk Proliferative Diabetic Retinopathy Submitted to Panretinal Photocoagulation and Associated Intravitreal Bevacizumab Injections: A Comparative, Randomised, Controlled Trial

By  

Ophthalmologica, Vol. 230, Iss. 1, 2013-05 ,pp. : 1-8

Karger

Access to resources Recommend Favorite

Is Smoking a Risk Factor for Proliferative Diabetic Retinopathy in Type 1 Diabetes?

By  

Ophthalmologica, Vol. 230, Iss. 1, 2013-06 ,pp. : 50-54

Karger

Access to resources Recommend Favorite

Dexamethasone Intravitreal Implant as Adjunctive Therapy to Ranibizumab in Neovascular Age-Related Macular Degeneration: A Multicenter Randomized Controlled Trial

By  

Ophthalmologica, Vol. 234, Iss. 1, 2015-06 ,pp. : 40-54

Karger

Access to resources Recommend Favorite

Changes in Adrenomedullin in Patients with Proliferative Diabetic Retinopathy

By Lu Yao   Xu Yimin   Tang Chaoshu  

Current Eye Research, Vol. 36, Iss. 11, 2011-11 ,pp. : 1047-1052

Informa Healthcare

Access to resources Recommend Favorite

Differential Expression of Vitreous Proteins in Proliferative Diabetic Retinopathy

By Kim Sang   Kim Sangmi   Park Jungeun   Lee Hong   Park Kyong   Yu Hyeong   Kim Youngsoo  

Current Eye Research, Vol. 31, Iss. 3, 2006-03 ,pp. : 231-240

Informa Healthcare

Access to resources Recommend Favorite